Andrew J. Carter, DO, FACC

Sirolimus-Eluting Stents for Treatment of Complex Bypass Graft Disease: Insights from the SECURE Registry

08/01/2008

Marco A. Costa , MD, PhD;

Andrew J. Carter , DO, FACC;

Paul S. Teirstein , MD, FACC;

Martin B. Leon , MD;

Martin Zenni , MD;

Theodore A. Bass , MD;

Steven J. Yakubov , MD;

Paul Gilmore , MD;

Jeffrey W. Moses , MD;

Tim A. Fischell , MD, FACC, FSCAI;

Dominick J. Angiolillo , MD, PhD;

Treatment options for bypass graft disease, such as repeat CABG and percutaneous revascularization, are limited and provide disappointing outcomes.1-4 Patients undergoing repeat CABG have over a four times greater rate of mortality compared...

Treatment options for bypass...

08/01/2008

Journal of Invasive Cardiology

CME/CEU Offering

06/19/2008

Andrew J. Carter , DO, FACC;

The following activity is supported by an unrestricted educational grant from Cordis Corporation. This presentation contains discussion of published and/or investigational uses of agents that are not indicated by the FDA. Neither HMP...

The following activity is...

06/19/2008

Cath Lab Digest

Commentary

Unprotected Left Main Stenting: An Alternative to CABG in a DES World?

08/01/2008

Tim A. Fischell , MD, FACC, FSCAI;

Andrew J. Carter , DO, FACC;

In this issue of the Journal of Invasive Cardiology, Eeckhout, et al. have described the adjunctive use of intravascular ultrasound to guide stent implantation in the treatment of symptomatic, “unprotected” left main coronary artery disease....

In this issue of the Journal of...

08/01/2008

Journal of Invasive Cardiology

Feature

CME/CEU Offering

06/19/2008

Andrew J. Carter , DO, FACC;

The following activity is...

06/19/2008

Cath Lab Digest